Join
Live feed
·
PRReleasevia Quantisnow
Applied Genetic Technologies Corporation logo

AGTC Announces Robust Improvements in Visual Sensitivity in Adult and Pediatric Patients, and Plans to Continue Clinical Development of AGTC-401 in Patients with CNGB3 Achromatopsia

ByQuantisnow·Wall Street's wire, on your screen.
AGTC· Applied Genetic Technologies Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGTC (Applied Genetic Technologies Corporation) and more on Quantisnow.